Literature DB >> 8453997

An oligomer targeted against protein kinase C alpha prevents interleukin-1 alpha induction of cyclooxygenase expression in human endothelial cells.

J A Maier1, G Ragnotti.   

Abstract

We have previously demonstrated that interleukin-1 alpha (IL-1), a potent polypeptide mediator of immune and inflammatory responses, induces the expression of cyclooxygenase (cox) in human endothelial cells. The mechanism by which binding of IL-1 to its receptor stimulates gene expression remains unclear. Since phorbol 12-myristate 13-acetate, which directly binds and activates protein kinase C (PKC), induced cox expression, we examined the role of PKC as an intracellular mediator of IL-1 activity in human endothelial cells. IL-1 induced the translocation of PKC from the cytosol to the membrane. H7, a selective inhibitor of PKC, as well as an antisense oligomer blocking PKC alpha translation suppressed IL-1 induction of cox mRNA. These findings establish that PKC plays a role in the signal transduction pathway leading to the induction of cox in human endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453997     DOI: 10.1006/excr.1993.1057

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

1.  TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment.

Authors:  Y Shimao; K Nabeshima; T Inoue; M Koono
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells.

Authors:  A Blanco; A Habib; S Levy-Toledano; J Maclouf
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

3.  Interleukin-1 beta induces expression of cyclooxygenase-2 mRNA in human gingival fibroblasts.

Authors:  T Yucel-Lindberg; H Ahola; S Nilsson; J Carlstedt-Duke; T Modéer
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.